Post by
JerryBo on May 11, 2020 6:00pm
Pot sector proved to be pandemic crisis-proof
declared essential services across US and Canada and with steady growth in sales. Q1 will be better and Q2 2020 will be very exciting for TGOD. If you need another leg, Tetra Bio Pharma (TBP) looks very promissing with a pipeline of products with DINs and others in clinical trials, including one drug in phase 2 clinical trials for covid-19. Shaping up to be a GW Pharma of Canada, right now US$109.
Comment by
JerryBo on May 11, 2020 7:26pm
https://www.laweekly.com/pot-industrys-best-april-yet-but-covid-19-hampers-growth/